Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check3 days agoChange DetectedA general notice about government funding delays was added and the page revision shows v3.4.1 replacing v3.4.0 — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoChange DetectedAdded a glossary toggle and updated site metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous QC label ('Last Update Submitted that met QC Criteria'), the lowercase 'data' label, and Revision: v3.3.4.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer; no changes to core study content such as title, conditions, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations section updated with new site entries across multiple countries (California, Connecticut, Illinois, Ohio, Oregon, Pennsylvania, Italy, New Zealand, Eastern Cape, Turkey). Revision tag updated to v3.3.3.SummaryDifference1.0%

- Check67 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1, which is a cosmetic metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1, with no changes to study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.